Bleeding Reports Prompt Pradaxa Label Changes
Pradaxa Add New Warnings To Its Label. Reports of Pradaxa bleeding side effects have prompted regulators in Canada - where it is sold as Pradax - to add new warnings to its label regarding use of the drug in kidney patients. New information will also be added to address use of Pradaxa in patients with severe valvular disease or … [Read more...]
Label Changes for Prescription Sleep Aids Announced in Canada
Prescription Sleep Aids. Health Canada has announced label updates for several medications used in the short-term treatment of insomnia. The prescription sleep aids subject to the label revision include: Dalmane, Som Pam (flurazepam) Mogadon, Nitrazadon (nitrazepam) Restoril (temazepam) Apo-Triazo … [Read more...]
FDA Steps Up Pain Relievers Warnings
FDA Warning On Pain Relievers. Federal health officials on Tuesday cautioned the tens of millions of Americans who take popular over-the-counter pain pills about their potentially serious side effects and released planned label changes intended to warn of the sometimes deadly risks. Aspirin, ibuprofen, acetaminophen and the other … [Read more...]
